Investing Valneva stock rises after positive final Phase 2 results for chikungunya vaccine Dylan D. DavisDecember 11, 2025 Valneva stock rises after positive final Phase 2 results for chikungunya vaccine Source link
Wednesday's big stock stories: What’s likely to move the market in the next trading session The S&P 500 and the Dow Industrials each posted a third straight losing session on Tuesday as investors contended with…
Weight-loss pill approval set to accelerate food industry product overhauls Weight-loss pill approval set to accelerate food industry product overhauls Source link
Medical supply firm Medline targets $39.5 billion valuation in blockbuster IPO (Dec. 8) Medical supply firm Medline targets $39.5 billion valuation in blockbuster IPO (Dec. 8) Source link